{
    "clinical_study": {
        "@rank": "126258", 
        "arm_group": [
            {
                "arm_group_label": "N1 group: Isoflurane & saline", 
                "arm_group_type": "Active Comparator", 
                "description": "for normal patients: inhale Isoflurane + the same volume of saline during operation"
            }, 
            {
                "arm_group_label": "N2 group: Isoflurane & Dexmedetomidine", 
                "arm_group_type": "Experimental", 
                "description": "for normal patients: inhale Isoflurane + intravenous pumping Dexmedetomidine during operation"
            }, 
            {
                "arm_group_label": "D1 group: Isoflurane & saline", 
                "arm_group_type": "Active Comparator", 
                "description": "for diabetes patients: inhale Isoflurane + the same volume of saline during operation"
            }, 
            {
                "arm_group_label": "D2 group: Isoflurane & Dexmedetomidi", 
                "arm_group_type": "Experimental", 
                "description": "for diabetes patients: inhale Isoflurane + intravenous pumping Dexmedetomidine during operation"
            }
        ], 
        "brief_summary": {
            "textblock": "Dexmedetomidine is a kind of high selectivity alpha 2 agonists adrenaline, can inhibit the\n      activity of sympathetic nerve, alleviate pain,and improve cardiovascular stability in the\n      operation period. Dexmedetomidine have influence on perioperative stress response and immune\n      function,but it is not clear."
        }, 
        "brief_title": "Dexmedetomidine Influence on the Level of Perioperative Blood Glucose and Insulin of Elderly Diabetes Patients", 
        "completion_date": {
            "#text": "October 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Perioperative Blood Glucose and Insulin", 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Aged 60 to 80 years old;\n\n          -  Type 2 diabetes;\n\n          -  Not use insulin treatment;\n\n          -  Onging general anesthesia surgery;\n\n          -  Surgery time 1-3 hours\n\n        Exclusion Criteria:\n\n          -  ASA classification > class II;\n\n          -  Hypertension;\n\n          -  Serious central nervous system diseases (acute stroke, uncontrolled seizures, -Severe\n             dementia);\n\n          -  Unstable angina and acute myocardial infarction;\n\n          -  Allergy to investigational drug;\n\n          -  Hepatic and renal dysfunction"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "80 Years", 
            "minimum_age": "60 Years"
        }, 
        "enrollment": {
            "#text": "92", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "May 28, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02154074", 
            "org_study_id": "Dexmedetomidine 20140527"
        }, 
        "intervention": [
            {
                "arm_group_label": [
                    "N1 group: Isoflurane & saline", 
                    "N2 group: Isoflurane & Dexmedetomidine", 
                    "D1 group: Isoflurane & saline", 
                    "D2 group: Isoflurane & Dexmedetomidi"
                ], 
                "description": "general anesthesia induction: midazolam 0.1mg/Kg, sufentanil 1ug/Kg, cisatracurium 0.15mg/Kg, and then immediatly administrate etomidate 0.2 mg/Kg", 
                "intervention_name": "general anesthesia induction", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": [
                    "N1 group: Isoflurane & saline", 
                    "N2 group: Isoflurane & Dexmedetomidine", 
                    "D1 group: Isoflurane & saline", 
                    "D2 group: Isoflurane & Dexmedetomidi"
                ], 
                "description": "inhale Isoflurane 1.5MAC", 
                "intervention_name": "Isoflurane", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": [
                    "N2 group: Isoflurane & Dexmedetomidine", 
                    "D2 group: Isoflurane & Dexmedetomidi"
                ], 
                "description": "anesthesia induction period: intravenous pumping Dexmedetomidine 4ug/Kg/h; after 10 minutes,turn to 0.4ug/Kg/h.", 
                "intervention_name": "Dexmedetomidine", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": [
                    "N1 group: Isoflurane & saline", 
                    "D1 group: Isoflurane & saline"
                ], 
                "description": "the same volume of saline + Isoflurane during operation", 
                "intervention_name": "normal saline", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Anesthetics", 
                "Isoflurane", 
                "Dexmedetomidine"
            ]
        }, 
        "is_fda_regulated": "No", 
        "keyword": "Dexmedetomidine perioperative blood glucose and insulin", 
        "lastchanged_date": "May 30, 2014", 
        "location": {
            "contact": {
                "email": "lannylouis@163.com", 
                "last_name": "Hongtao Liu", 
                "phone": "13572225310"
            }, 
            "facility": {
                "address": {
                    "city": "Xi'an", 
                    "country": "China", 
                    "state": "Shanxi"
                }, 
                "name": "SecondXianJiaotongU"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "China"
        }, 
        "number_of_arms": "4", 
        "overall_contact": {
            "email": "lannylouis@163.com", 
            "last_name": "Hongtao Liu", 
            "phone": "13572225310"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "China: Food and Drug Administration", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "October 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": [
            {
                "description": "measure blood glucose at 3 time points,the day before surgery,Intraoperative(1 hour after surgery begain),one day after surgery(24 hours after surgery); examine the concentration of blood glucose in serum.", 
                "measure": "blood glucose", 
                "safety_issue": "Yes", 
                "time_frame": "from the day before surgery to 24 hours after surgery"
            }, 
            {
                "description": "measure the level of blood insulin at 3 time points,the day before surgery,Intraoperative(1 hour after surgery begain),one day after surgery(24 hours after surgery); use ELISA to examine the concentration of blood insulin in serum.", 
                "measure": "level of blood insulin", 
                "safety_issue": "Yes", 
                "time_frame": "from the day before surgery to 24 hours after surgery"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02154074"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "description": "measure the blood pressure(BP),heart rate(HR) and oxygen saturation(SpO2) in the perioperative period", 
            "measure": "vital signs", 
            "safety_issue": "Yes", 
            "time_frame": "duration of perioperative period"
        }, 
        "source": "Second Affiliated Hospital of Xi'an Jiaotong University", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Second Affiliated Hospital of Xi'an Jiaotong University", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "May 2014", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "May 2014"
    }
}